Scots-Knight Denise insider trades

Scots-Knight Denise has filed 13 Form 4s with the SEC that we hold, for Mereo BioPharma Group plc (MREO) (Chief Executive Officer, Director) and Elanco Animal Health Inc (ELAN) (Director). Across all of them we count 0 purchases worth $0 and 4 sales worth $844.3K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 92,273 shares of Mereo BioPharma Group plc worth $312.8K, dated 2024-06-26. The first filing on our record is dated 2021-12-02 and the latest 2026-05-26.

Mereo BioPharma Group plc (MREO)

Chief Executive Officer, Director · 7 filings · 4 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2024-06-25	S, sale reported on Form 4	40,712	$150.2K	2024-06-27	SEC
2024-06-26	S, sale reported on Form 4	92,273	$312.8K	2024-06-27	SEC
2024-09-12	S, sale reported on Form 4	28,611	$127.9K	2024-09-16	SEC
2024-09-13	S, sale reported on Form 4	60,046	$253.4K	2024-09-16	SEC

Elanco Animal Health Inc (ELAN)

Director · 6 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1297000) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms